Vir Bio inks $362M Covid-19 contract manufacturing deal with Samsung Biologics

Vir Bio inks $362M Covid-19 contract manufacturing deal with Samsung Biologics

Source: 
MedCity News
snippet: 

Vir Biotechnology, based in San Francisco, has lately made several high-profile development and manufacturing deals with drug companies as well as contract manufacturers, amid the Covid-19 pandemic. Manufacturing is expected to start in October.